Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

- PMLiVE

Omnichannel: from theory to successful implementation

By Carrie Evans

Pharma website design trends 2025

Web Design Strategies for Pharma & Life Sciences in 2025

As we approach 2025, healthcare and life sciences SMEs face an increasingly digital world. A seamless, mobile-friendly website that harnesses AI-driven personalisation and intuitive design elements isn’t just a luxury...

Genetic Digital

QR codes for prescribing info

Leveraging the ABPI QR Code Update: Enhancing Prescribing Information Through Best Practices

ABPI's recent update permits QR codes in printed pharmaceutical materials for prescribing information. By ensuring visibility, providing clear instructions, linking directly, and keeping content current, companies can enhance accessibility, ensure...

Genetic Digital

Pi 360 – Digital PI & QR Code Tool

Pi 360 – A Smarter, Automated Solution for Digital Prescribing Information (PI) & QR Code Compliance

Life sciences digital agency Genetic Digital has launched Pi 360, a cutting-edge web application designed to help pharmaceutical companies automate the creation, management and distribution of Prescribing Information (PI) while...

Genetic Digital

Pharma SEO

Hidden in Plain Sight: The Compliance Risks of Search Engine Indexed Pharma Content

Pharma companies must balance HCP access and MHRA/ABPI compliance by preventing public search indexing of promotional prescription medicine content.

Genetic Digital

Boost Publication Collaboration Virtually – Engaging Your Advisors Creatively

Tired of traditional advisory board limitations? Explore innovative ways to engage your KOLs, HCPs, and MSLs in our new series! Learn how to co-create impactful publications virtually in our first...

Impetus Digital

- PMLiVE

Sanofi expands immunology pipeline by acquiring Dren’s bispecific for $600m upfront

The candidate has shown potential in treating B-cell mediated autoimmune diseases

- PMLiVE

AstraZeneca’s Imfinzi granted EC approval for limited-stage small cell lung cancer

The drug is already approved in the EU to treat extensive stages of the disease

- PMLiVE

Novartis shares positive phase 3 results for spinal muscular atrophy gene therapy

The company said it is planning to file regulatory applications for OAV101 IT this year

- PMLiVE

Harnessing AI and big data in clinical research

By Sheila Kelly

- PMLiVE

Pfizer/Arvinas’ vepdegestrant shows promise in phase 3 breast cancer study

It is estimated that nearly 320,000 people will be diagnosed with the disease in the US this year

- PMLiVE

AbbVie’s Elahere shows consistent survival benefits in late-stage ovarian cancer trial

Approximately 20,000 cases of the disease are diagnosed in the US every year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links